Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
12
×
boston blog main
boston top stories
12
×
life sciences
national blog main
clinical trials
boston
fda
national top stories
san francisco blog main
investing
deals
medical device
new york blog main
raleigh-durham blog main
san diego blog main
san francisco top stories
seattle blog main
startups
indiana blog main
ipo
raleigh-durham top stories
san diego top stories
seattle top stories
software
venture capital
boulder/denver blog main
boulder/denver top stories
cancer
crispr
detroit blog main
detroit top stories
digital health
drug delivery
eventide asset management
gene editing
glaxosmithkline
indiana top stories
medical devices
medicare
What
million
12
×
ipo
new
therapeutics
raised
company
drug
medicines
clinical
developing
raises
startup
tests
bio
biosciences
biotech
bio’s
brings
cancer
closed
crispr
digital
genetic
patients
pipeline
public
sciences
tiny
treat
adding
adds
aiming
allergan
alliance
allogene
analysis
analytics
areas
based
begin
Language
unset
Current search:
million
×
biotech
×
" boston top stories "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
Renovia Raises $42M to Back Digital Treatment for Incontinence
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M